Earnings Release • Feb 26, 2020
Earnings Release
Open in ViewerOpens in native device viewer
Vilmorin & Cie SA Public limited company with Board of Directors with a capital of 349,488,703 euros Head Office: 4, Quai de la Mégisserie – F-75001 PARIS SIREN Paris 377 913 728 Fiscal year from July 1 st to June 30th Euronext Paris (Compartment A) – Eligible for Deferred Settlement Order Indices: CAC Small, CAC Mid & Small and CAC All-Tradable

February 26, 2020, at 5:40 pm CET
NET INCOME FOR THE 1ST SEMESTER 2019-2020: -63.4 MILLION EUROS
CONFIRMATION OF THE OBJECTIVES FOR FISCAL YEAR 2019-2020
* With current data
On average, sales for the first semester globally represent around only one third of the annual sales for Vilmorin & Cie. Because of this highly seasonal pattern, the consolidated financial statements for the first semester traditionally show very negative income.
| In millions of euros | 2018-2019 | 2019-2020 | Variation with current data |
Variation on a like-for like basis |
|---|---|---|---|---|
| Sales | ||||
| Vegetable Seeds | 239.2 | 248.4 | +3.9% | +1.9% |
| Field Seeds | 209.0 | 228.9 | +9.5% | +2.5% |
| Garden Products and Holdings | 12.2 | 13.5 | +10.3% | +14.5% |
| Sales for the first semester | 460.4 | 490.8 | +6.6% | +2.5% |
| In millions of euros | 2018-2019 | 2019-2020 | Variation with current data |
|---|---|---|---|
| EBITDA | 62.4 | 70.9 | +8.5 |
| Operating income | -40.5 | -46.7 | -6.2 |
| Income from associated companies | -7.9 | -22.4 | -14.5 |
| Financial income | -19.4 | -23.0 | -3.6 |
| Income taxes | +28.2 | +28.7 | +0.5 |
| Net income of which group share |
-39.6 -39.2 |
-63.4 -61.9 |
-23.8 -22.7 |
The consolidated financial statements for the first semester 2019-2020, closed on December 31, 2019, were approved at the Vilmorin & Cie Board meeting of February 26, 2020. The Statutory Auditors have carried out a limited audit of the financial information for the first semester; in their conclusions they have not indicated any reservations or particular remarks.
Consolidated financial information is established in compliance with the IFRS referential (International Financial Reporting Standards) as endorsed by the European Union on December 31, 2019. It takes into account the application of IAS 29 with regard to the treatment of hyperinflation, applied to activities in Argentina and also by Seed Co1 for its activities in Zimbabwe.
VILMORIN & CIE PRESS RELEASE FEBRUARY 26, 2020 1
1 On December 31, 2019, Vilmorin & Cie held 29.4% of Seed Co Limited's capital stock and 31% of Seed Co International's capital stock.
In addition, the accounting principles and methods adopted in the condensed consolidated financial statements for the first semester on December 31, 2019 have changed compared to June 30, 2019 to take into account the first application of IFRS 16, the impacts of which are presented in detail in appendix 6, as well as the first application of IFRIC 23, which had no impact on the financial statements of Vilmorin & Cie.
No other change in accounting methods or estimates with any impact on Vilmorin & Cie's consolidated financial statements was applied by Vilmorin & Cie over the course of the semester.
Over the second quarter, the Vegetable Seeds division made sales of 139.8 million euros, an increase of 3% with current data, and 1.2% on a like-for-like basis.
All the geographical zones posted growth in business, with the exception of Asia, affected in particular by delays in carrot orders in China. Following on from the first quarter, the increase in sales was particularly dynamic in North America - both in the United States and Mexico - in South America and the Middle East, particularly in Turkey.
With regard to the different crops, tomato, onion, pepper and carrot achieved the best performances, demonstrating the high quality of Vilmorin & Cie's product portfolio.
Finally, it should be noted that the increase in sales posted over the quarter concerns all three Business Units - HM.CLAUSE, Hazera and Vilmorin-Mikado, allowing Vilmorin & Cie to cover the highly fragmented vegetable seed markets with efficiency.
Consequently, sales for the Vegetable Seeds division for the first semester came to 248.4 million euros, an increase of 3.9%. Restated on a like-for-like basis, they rose by 1.9%. This result means that Vilmorin & Cie can confirm its position as N°1 worldwide for vegetable seeds.
At the end of a first semester that represents, on average over the last few years, less than 40% of annual sales, Vilmorin & Cie confirms its sales growth target for this activity for 2019-2020, i.e. an increase of 3% on a like-for-like basis compared to 2018-2019.
Over the second quarter, Field Seeds posted sales that were virtually stable with current data (+0.2%) and down by 2.6% on a like-for-like basis.
In Europe, Vilmorin & Cie posted a drop in business over the second quarter, largely as a result of a delay in sales of corn seed compared with December 31, 2018. After a first quarter posting significant growth in sales, this slow-down does not call into question the outlook for the 2020 sales campaign: the order books look promising and fuller than last year, with corn acreage that should slightly increase. With regard to orders for the sunflower seeds campaign, they are holding up well, in a context of lower acreage predicted for this crop.
Furthermore, Vilmorin & Cie once again this year posted an excellent rapeseed campaign, with a very sharp increase in sales. This performance was all the more remarkable as it was achieved in the context of a strong drop in acreage devoted to this crop. As a result, Vilmorin & Cie has gained very significant market shares and is now positioned among the top European players for this crop.
As for the first part of the straw cereal seed (wheat, barley) campaign, sales were down in the context of a slight drop in cultivated acreage. Similarly, sales of forage crop seeds, which complement the commercial offer in Europe, fell, particularly in Germany and the Netherlands.
In South America, sales were up significantly at the end of December, materializing Vilmorin & Cie's reinforced commercial presence on this continent of such great potential. In Brazil, sales for the first corn campaign (safra) were down compared with the previous year, whereas the second campaign (safrinha) has made a promising start, in a more favorable market environment this year. Sales of soybean seeds have experienced very high growth; as a consequence, Vilmorin & Cie is continuing to strengthen its positions for this major crop in South America.
Finally, in Argentina, sales increased noticeably. Integration of the company Sursem, acquired in December 2018, has now been finalized and it has contributed significantly to the increase in sales in the country.
In the other development regions, business in South Africa was down slightly, whereas in Asia, sales showed strong growth, thanks to a very good performance on the Indian market.
Consequently, sales for the Field Seeds division for the first semester came to 228.9 million euros, an increase of 9.5% with current data, and 2.5% on a like-for-like basis compared with the first semester for 2018-2019.
Moreover, with regard to associated companies:
After taking into account the cost of destruction and impairment of inventory, margin on the cost of sales came to 255.3 million euros and represents 52% of total sales, a strong increase of 2.3 percentage points on a like-for-like basis compared to the first semester for the previous fiscal year; over the semester it mainly benefitted from the increase in margins for Field Seeds.
Net operating charges came to 302 million euros, an increase of 28.5 million euros with current data compared to the first semester for fiscal year 2018-2019. Nevertheless, it should be noted that the first semester of the previous fiscal year included an exceptional income resulting from the partial demerger of Biogemma, a biotechnology research company of which Vilmorin & Cie is now the sole shareholder.
Consequently, the operating income for the first semester shows a loss of 46.7 million euros on December 31, 2019, an increase of 6.2 million euros compared to the first semester for 2018-2019; the operating margin, traditionally negative at the end of the first semester, came to -9.5%, as opposed to -8.8% on December 31, 2018.
The income contribution from associated companies, in particular AgReliant (North America. Field Seeds) and Seed Co (Africa. Field Seeds), stood at -22.4 million euros at the end of the first semester for 2019-2020, as opposed to -7.9 million euros for the first semester of the previous fiscal year, which took into account a revaluation profit of 11 million euros, as a result of the financial and legal reorganization of the company Seed Co's international activities.
1 At the end of the first semester (on September 30, 2019).
2 Cf. "Seed Co International Limited Abridged Group unaudited results for the half year ended 30 September 2019" available on the website www.seedcogroup.com.
It should be reminded that, following the Annual General Meeting held on December 6, 2019, the Board of Directors met to appoint a successor to Philippe AYMARD, Chairman and CEO, and designated, with the same functions, Sébastien VIDAL, a Board Member of Vilmorin & Cie since 20161 ; the Board also confirmed Daniel JACQUEMOND's mandate as Delegate CEO.
Moreover, the Annual General Meeting appointed Marie-Yvonne CHARLEMAGNE as Independent Board Member1 to replace Miriam MAES whose term of office expired, and who, in agreement with the Board of Directors, did not wish to renew it.
Furthermore, on February 26, 2020, the Board of Directors co-opted Philippe BLATEYRON as Board Member for Vilmorin & Cie. Philippe BLATEYRON is a farmer and has been a Board Member of Limagrain since 2009; he has been Vice President since January 2020, and has held several mandates within the Group's different divisions, particularly for the Vegetable Seeds activity.
Dedicated to the development of GM corn proprietary traits, Genective, a 50/50 joint venture with the German seed company KWS, recently announced that it has signed a partnership agreement with AgBiome, a leading American company specializing in microbial technology for crop protection. Through this partnership, Genective will have access to all the genes of resistance to insects identified by AgBiome.
This multi-year program will provide Genective with considerable capabilities to discover new modes of action to fight against the main corn pests, as an alternative to agrochemical treatment products.
Building on this work, Vilmorin & Cie aims eventually to offer a proprietary line-up of genetically modified seed corn varieties. Vilmorin & Cie will thus be able to position itself among the few global players providing these technologies.
1 Cf. Vilmorin & Cie press release of December 9, 2019.
Vilmorin & Cie has announced it has signed a long-term funding agreement with the European Investment Bank (EIB). Finalized with highly favorable conditions, this funding, for a total of 170 million euros, involves two maturity tranches at 5 years and 7 years. It will be dedicated to Vilmorin & Cie's R&D projects, thus illustrating the support of a major European institution for the Company's strategy on seed research, the first link in the food chain.
Following on from the refinancing of its 300 million euros syndicated bank loan in May 2019, and the 250 million euros "Schuldschein" private placement successfully completed in June 2019, Vilmorin & Cie continues to confirm its ability to diversify and make its financial resources more flexible.
Vilmorin & Cie has announced the creation, in partnership with Seed Co, of a joint venture primarily dedicated to seed corn located in Ghana. It is operationally established between Vilmorin & Cie and Seed Co International and is equally owned by the two companies. This new structure will make it possible to specifically address the West and Central African market.
The creation of this entity is reliant on the complementarities between Vilmorin & Cie and Seed Co, which is the leading African seed company, and marks the intensification of collaboration between the two companies. It should be remembered that Vilmorin & Cie is the reference shareholder of Seed Co1 .
Vilmorin & Cie has thus entered a new stage in the deployment of its activities in Africa and can confirm its desire to significantly accelerate its expansion on this continent, which promises considerable development.
In view of the results for the first semester, as presented above, and on the basis of information currently available, Vilmorin & Cie confirms its objectives for sales and current operating margin for fiscal year 2019-2020.
These correspond to an increase in consolidated sales of 2% to 3% on a like-for-like basis, and a current operating margin rate of at least 8%, including research investment which should be higher than 255 million euros.
Over the second semester, reaching these objectives will nevertheless partly depend on:
1 On December 31, 2019, Vilmorin & Cie held 29.4% of Seed Co Limited's capital stock and 31% of Seed Co International's capital stock.
You can consult a presentation of sales and results at the end of the first semester on the home page of the website www.vilmorincie.com
Dates provided as an indication only, and liable to be changed. (1) Disclosure after trading on the Paris Stock Market.
Vincent SUPIOT Chief Financial Officer [email protected]
Valérie MONSÉRAT Head of Financial Communication and Investor Relations [email protected]
Tel: + 33 (0)4 73 63 44 85 www.vilmorincie.com

Vilmorin & Cie, the 4th largest seed company in the world, develops vegetable and field seeds with high added value, contributing to meeting global food requirements.
Accompanied by its reference shareholder Limagrain, both an agricultural cooperative owned by French farmers and an international seed group, Vilmorin & Cie's strategy for growth relies on strong, sustained investments in research and international development to durably strengthen its market shares on promising world markets.
True to its vision of sustainable development, Vilmorin & Cie ensures its achievements fully respect its three founding values: progress, at the heart of its beliefs and its mission, perseverance, inherent to farming and the seeds business, and cooperation, in the fields of science, industry and commerce.
| In millions of euros | 2018-2019 | 2019-2020 | Variation with current data |
Variation on a like-for like basis |
Of which: Impact of currency |
Impact of scope |
|---|---|---|---|---|---|---|
| First quarter | 207.5 | 231.9 | +11.8% | +5.2% | +1.8 | +11.2 |
| Vegetable Seeds | 103.4 | 108.6 | +5.0% | +2.8% | +2.2 | 0.0 |
| Field Seeds | 96.5 | 116.1 | +20.3% | +7.9% | -0.4 | +11.6 |
| Garden Products and Holdings |
7.6 | 7.3 | -4.9% | +0.1% | 0.0 | -0.4 |
| Second quarter | 252.9 | 258.9 | +2.3% | +0.2% | +1.8 | +3.7 |
| Vegetable Seeds | 135.8 | 139.8 | +3.0% | +1.2% | +2.4 | 0.0 |
| Field Seeds | 112.6 | 112.8 | +0.2% | -2.6% | -0.6 | +3.8 |
| Garden Products and Holdings |
4.6 | 6.2 | +35.6% | +37.7% | 0.0 | -0.1 |
| First semester | 460.4 | 490.8 | +6.6% | +2.5% | +3.6 | +14.9 |
| Vegetable Seeds | 239.2 | 248.4 | +3.9% | +1.9% | +4.6 | 0.0 |
| Field Seeds | 209.0 | 228.9 | +9.5% | +2.5% | -1.0 | +15.4 |
| Garden Products and Holdings |
12.2 | 13.5 | +10.3% | +14.5% | 0.0 | -0.5 |
| 12.31.18 | ||||
|---|---|---|---|---|
| In millions of euros | 12.31.19 | Restated(1) | Disclosed | |
| ■ Revenue from ordinary activities |
490.8 | 460.4 | 460.4 | |
| Cost of goods sold | - 235.5 | - 227.4 | - 227.4 | |
| Marketing and sales costs | - 100.4 | - 93.8 | - 93.8 | |
| Research and development costs | - 107.8 | - 96.0 | - 96.0 | |
| Administrative and general costs | - 97.3 | - 92.9 | - 92.9 | |
| Other operating income and charges | 3.5 | 10.5 | 9.2 | |
| ■ Operating income |
- 46.7 | - 39.2 | - 40.5 | |
| Profit from associated companies | - 22.4 | - 7.9 | - 7.9 | |
| Interest costs | - 16.9 | - 12.7 | - 12.7 | |
| Other financial income and charges | - 6.1 | - 8.3 | - 6.7 | |
| Income taxes | 28.7 | 28.3 | 28.2 | |
| ■ Profit from continuing operations |
- 63.4 | - 39.8 | - 39.6 | |
| ■ Profit from discontinued operations |
- | - | - | |
| ■ Net income for the period |
- 63.4 | - 39.8 | - 39.6 | |
| > Attributable to controlling company | - 61.9 | - 39.4 | - 39.2 | |
| > Attributable to non-controlling minority | - 1.5 | - 0.4 | - 0.4 | |
| Earnings from continuing operations per share - attributable to controlling company |
- 2.70 | - 1.89 | - 1.88 | |
| Earnings from discontinued operations per share - attributable to controlling company |
- | - | - | |
| Earnings for the period per share | - 2.70 | - 1.89 | - 1.88 | |
| - attributable to controlling company | ||||
| Diluted earnings from continuing operations per | ||||
| share | - 2.62 | - 1.83 | - 1.82 | |
| - attributable to controlling company Diluted earnings from discontinued operations per |
||||
| share | - | - | - | |
| - attributable to controlling company Diluted earnings for the period per share |
||||
| - attributable to controlling company | - 2.62 | - 1.83 | - 1.82 |
| 12.31.18 | ||||
|---|---|---|---|---|
| In millions of euros | 12.31.19 | Restated(1) | Disclosed | |
| Income for the period | - 63.4 | - 39.8 | - 39.6 | |
| Variation in currency translation | - 7.8 | - 4.9 | - 4.9 | |
| Variation in the fair value of assets for sale | - | - | - | |
| Variation in the fair value of financial instruments | - | - 0.7 | - 0.7 | |
| Change in method | - | - | - | |
| Impact of taxes | - | 0.2 | 0.2 | |
| Items that might be reclassified to profit or loss | - 7.8 | - 5.4 | - 5.4 | |
| Actuarial gains or losses | - 3.9 | 3.2 | 3.2 | |
| Impact of taxes | 0.8 | - 0.6 | - 0.6 | |
| Items not to be reclassified to profit or loss | - 3.1 | 2.6 | 2.6 | |
| Other items in the total gains and losses for the period net of taxes |
- 10.9 | - 2.8 | - 2.8 | |
| Total gains and losses for the period | - 74.3 | - 42.6 | - 42.4 | |
| > Of which attributable to controlling company | - 72.7 | - 41.1 | - 40.9 | |
| > Of which attributable to non-controlling minority | - 1.6 | - 1.5 | - 1.5 |
| 06.30.19 | ||||
|---|---|---|---|---|
| In millions of euros | 12.31.19 | Restated(1) | Disclosed | |
| Goodwill | 439.7 | 434.8 | 434.8 | |
| Other intangible fixed assets | 733.2 | 739.5 | 739.5 | |
| Tangible fixed assets | 290.7 | 292.4 | 292.8 | |
| Right-of-use leased assets | 71.1 | 68.7 | ||
| Financial fixed assets | 29.9 | 29.9 | 29.9 | |
| Equity shares | 321.2 | 349.1 | 349.1 | |
| Deferred taxes | 26.1 | 25.0 | 23.8 | |
| ■ Total non-current assets |
1,911.9 | 1,939.4 | 1,869.9 | |
| Inventories | 732.6 | 533.7 | 533.7 | |
| Trade receivables and other receivables | 510.9 | 526.7 | 526.7 | |
| Cash and cash equivalents | 207.9 | 248.7 | 248.7 | |
| Assets held for sale | 7.8 | - | - | |
| ■ Total current assets |
1,459.2 | 1,309.1 | 1,309.1 | |
| Total assets | 3,371.1 | 3,248.5 | 3,179.0 |
| 06.30.19 | ||||
|---|---|---|---|---|
| In millions of euros | 12.31.19 | Restated(1) | Disclosed | |
| Share capital | 349.5 | 349.5 | 349.5 | |
| Reserves and income | 780.7 | 883.8 | 886.4 | |
| ■ Equity – controlling company |
1,130.2 | 1,233.3 | 1,235.9 | |
| ■ Equity – non-controlling minorities |
86.5 | 87.9 | 88.0 | |
| ■ Consolidated equity |
1,216.7 | 1,321.2 | 1,323.9 | |
| Provisions for employee benefits | 66.4 | 61.7 | 61.7 | |
| Non-current financial debts | 1,097.2 | 964.0 | 964.4 | |
| Non-current lease obligations | 49.0 | 52.1 | ||
| Deferred income taxes | 79.2 | 99.3 | 99.1 | |
| ■ Total non-current liabilities |
1,291.8 | 1,177.1 | 1,125.2 | |
| Other provisions | 11.6 | 15.2 | 15.2 | |
| Accounts payable | 418.1 | 489.4 | 489.4 | |
| Deferred income | 29.9 | 29.0 | 29.0 | |
| Current financial debts | 372.2 | 196.2 | 196.3 | |
| Current lease obligations | 25.2 | 20.4 | ||
| Liabilities directly related to the group of assets held for sale |
5.6 | - | - | |
| ■ Total current liabilities |
862.6 | 750.2 | 729.9 | |
| Total liabilities | 3,371.1 | 3,248.5 | 3,179.0 |
| Attributable to controlling company | Attributable | ||||||
|---|---|---|---|---|---|---|---|
| In millions of euros | Capital | Premiums | Income and other reserves |
Currency translation reserves |
Total | to non controlling minorities |
Total |
| 07.01.18 disclosed | 317.7 | 332.4 | 596.7 | - 51.8 | 1,195.0 | 109.7 | 1,304.7 |
| Impacts of the application of IFRS16 | - | - | - 2.9 | 0.1 | - 2.7 | - 0.1 | - 2.8 |
| 07.01.18 restated | 317.7 | 332.4 | 593.8 | - 51.7 | 1,192.2 | 109.6 | 1,301.8 |
| Other items in the global income net of taxes |
- | - | - 4.2 | - 19.0 | - 23.2 | - 1.4 | - 24.6 |
| Net income | - | - | 74.0 | - | 74.0 | 4.0 | 78.0 |
| Global income for the fiscal year | - | - | 69.8 | - 19.0 | 50.8 | 2.6 | 53.4 |
| Variation in treasury shares | - | - | 0.1 | - | 0.1 | - | 0.1 |
| Dividends paid out | - | - | - 28.0 | - | - 28.0 | - 2.6 | - 30.6 |
| Variations in scope | - | - | - 1.1 | - | - 1.1 | - | - 1.1 |
| Effect of share purchase commitments | - | - | - | - | - | - | - |
| Variation in the capital stock of the parent company |
31.8 | - 31.8 | - | - | - | - | - |
| Variation in the capital stock of the subsidiaries |
- | - | - 4.4 | - | - 4.4 | 0.1 | - 4.3 |
| Variation in minority interest shares | - | - | 5.2 | 8.4 | 13.6 | - 21.9 | - 8.3 |
| Bonds redeemable as shares | - | - | - | - | - | - | - |
| Impact of hyperinflationary currency adjustments |
- | - | 11.2 | - | 11.2 | 0.1 | 11.3 |
| Reclassifications | - | - | - 3.5 | 3.5 | - | - | - |
| Others | - | - | - 1.1 | - | - 1.1 | - | - 1.1 |
| 06.30.19 restated | 349.5 | 300.6 | 642.0 | - 58.8 | 1,233.3 | 87.9 | 1,321.2 |
| Other items in the global income net of taxes |
- | - | - 3.0 | - 7.8 | - 10.8 | - 0.1 | - 10.9 |
| Net income | - | - | - 61.9 | - | - 61.9 | - 1.5 | - 63.4 |
| Global income for the fiscal year | - | - | - 64.9 | - 7.8 | - 72.7 | - 1.6 | - 74.3 |
| Variation in treasury shares | - | - | - 0.1 | - | - 0.1 | - | - 0.1 |
| Dividends paid out | - | - | - 31.1 | - | - 31.1 | - 0.5 | - 31.6 |
| Variations in scope | - | - | - | - | - | - | - |
| Effect of share purchase commitments | - | - | - | - | - | - | - |
| Variation in the capital stock of the parent company |
- | - | - | - | - | - | - |
| Variation in the capital stock of the subsidiaries |
- | - | - 2.6 | - | - 2.6 | 0.7 | - 1.9 |
| Variation in minority interest shares | - | - | - 0.6 | - | - 0.6 | - | - 0.6 |
| Bonds redeemable as shares | - | - | - | - | - | - | - |
| Restatement for hyperinflation | - | - | 4.3 | - | 4.3 | - | 4.3 |
| Reclassifications | - | - | 0.7 | - 0.7 | - | - | - |
| Others | - | - | - 0.3 | - | - 0.3 | - | - 0.3 |
| 12.31.19 | 349.5 | 300.6 | 547.4 | - 67.3 | 1,130.2 | 86.5 | 1,216.7 |
| In M€ | S1 2019/2020 before IFRS 16 |
Impact IFRS 16 |
S1 2019/2020 including IFRS 16 |
|---|---|---|---|
| Revenue from ordinary activities | 490.8 | 490.8 | |
| Cancellation of leases | 12.8 | 12.8 | |
| EBITDA | 58.1 | 12.8 | 70.9 |
| Amortization of leasing contracts | -10.9 | -10.9 | |
| Operating income | -48.6 | 1.9 | -46.7 |
| Profit from associated companies | -22.4 | -22.4 | |
| Interest costs | -16.9 | -16.9 | |
| Interest costs related to leasing contract | -1.6 | -1.6 | |
| Other financial income and charges | -4.5 | -4.5 | |
| Income taxes | 28.8 | -0.1 | 28.7 |
| Net income for the period | -63.6 | 0.2 | -63.4 |
| S1 2019/2020 | Impact | S1 2019/2020 | |
|---|---|---|---|
| In M€ | before IFRS 16 | IFRS 16 | including IFRS 16 |
| Intangible fixed assets | 1,172.9 | 1,172.9 | |
| Tangible fixed assets | 291.4 | -0.7 | 290.7 |
| Right-of-use leased assets | 71.1 | 71.1 | |
| Financial fixed assets | 351.1 | 351.1 | |
| Deferred taxes | 25.2 | 0.9 | 26.1 |
| Current assets | 1,251.3 | 1,251.3 | |
| Cash and cash equivalents | 207.9 | 207.9 | |
| TOTAL ASSETS | 3,299.8 | 71.3 | 3,371.1 |
| Consolidated equity | 1,219.2 | -2.5 | 1,216.7 |
| Financial debts | 1,469.8 | -0.4 | 1,469.4 |
| Lease obligations | 74.2 | 74.2 | |
| Other liabilities | 610.8 | 610.8 | |
| TOTAL LIABILITIES | 3,299.8 | 71.3 | 3,371.1 |
Like-for-like data is data that is restated for constant scope and currency translation. Therefore, financial data for 2018-2019 is restated with the average rate for fiscal year 2019-2020, and any other changes to the scope, in order to be comparable with data for fiscal year 2019-2020.
Variations in the consolidated scope come from the acquisition of the companies Sursem and Geneze (South America. Field Seeds) finalized in December 2018 and from the sale of the company Van Den Berg (Netherlands. Garden Products) in June 2019.
Current data is data expressed at the historical currency exchange rate for the period, and without adjustment for any changes in scope.
The EBITDA is defined as the operating result to which are added any provisions for depreciation, amortization and impairment.
Financial indebtedness corresponds to the financial debts less cash and cash equivalents.
Research investment corresponds to gross research expenditure before recording as fixed assets any research costs and research tax relief.
The current operating margin is defined as the accounting operating margin restated for any impairment and reorganization costs.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.